CORRECTED: Diabetes Company Valeritas Prices $54M Offering
Insulin device maker Valeritas Inc. priced a $53.5 million public offering Thursday under guidance from Morgan Lewis & Bockius LLP, marking the company's second attempt at an IPO after pulling earlier...To view the full article, register now.
Already a subscriber? Click here to view full article